Viela Bio (Kidney Transplant) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about how the study drug (VIB4920) given with Belatacept (an Immunosuppressive drug) can help stop rejection of a kidney transplant.
Who Can Participate in the Study?
- Adults 18-70
- Never had a kidney transplant
What is Involved?
If you choose to join this study you will:
- Complete physical
- Give blood samples
- Get ECG (looking at electrical activity of the heart)
- Complete follow-up visits for 15 months (every other week for 3 months and then once a month)